BD² Unveils $18M Grants to Advance Bipolar Disorder Research Worldwide

BD² announced $18 million in grants to boost global research on Bipolar disorder, aiming to uncover its mechanisms through innovative approaches like neuromodulation.

BD² has unveiled nearly $18 million in grants to support research on Bipolar disorder, with projects led by teams from the Icahn School of Medicine at Mount Sinai and Mass General Brigham.
The research will focus on understanding the neural circuit mechanisms of Bipolar disorder, utilizing techniques such as deep brain stimulation to explore potential treatments.
Prominent institutions like Weill Cornell Medicine and the University of Minnesota are involved, highlighting a collaborative effort to advance knowledge in mental health.

Why It Matters

This funding represents a significant investment in mental health research, potentially leading to breakthroughs in treatment for Bipolar disorder and improving the lives of millions affected globally.